Meridian Bioscience Recognized as One of the 100 Best Small Companies of 2005 by Business Week Magazine
CINCINNATI--(BUSINESS WIRE)--June 1, 2005--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO) today announced that it has been recognized by Business Week magazine as one of "The 100 Best Small Companies." The 100 Best Small Companies list is selected following a comprehensive evaluation of financial results plus additional operating factors of candidate companies having sales between $50 million and $1.5 billion. Additional qualification criteria included rankings based upon sales and earnings growth, plus return on capital over three years. Meridian Bioscience's overall ranking was 86 and demonstrated three-year average earnings growth of 35.1% and a return on capital rate of 13.8.
John A. Kraeutler, President and Chief Operating Officer, stated, "This recognition of Meridian Bioscience by Business Week reinforces our commitment to innovation and quality as we develop, manufacture, and distribute products and services that provide cost-effective solutions for the healthcare consumer. Being chosen as a "Hot Growth" star, alongside companies such as Pixar (PIXR) and Urban Outfitters (URBN), is very rewarding to Meridian and its employees around the world.
Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral, and respiratory infections. Meridian diagnostic products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents and specialty biologicals along with proteins and other biologicals used by biopharmaceutical companies engaged in research for new drugs and vaccines. The Company markets its products to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices and diagnostics manufacturers in more than 60 countries around the world. The Company's shares are traded through Nasdaq's National Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com.
CONTACT: Meridian Bioscience, Inc.
John A. Kraeutler, 513-271-3700
SOURCE: Meridian Bioscience, Inc.